Is Novelstem International Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Novelstem International Corp (NSTM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Novelstem International Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Novelstem International Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Novelstem International Corp?

Muslim investors may consider investing in Novelstem International Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Novelstem International Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Novelstem International Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Novelstem International Corp updated?

The Shariah compliance status of Novelstem International Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Novelstem International Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Novelstem International Corp?

You can check the latest Shariah compliance status of Novelstem International Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Novelstem International Corp. Stock Analysis NSTM

United States Health Care Nano Cap

NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company is headquartered in Boca Raton, Florida. The firm's primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. Its NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. NetCo is a media business interest which owns Net Force, a book publishing franchise.

Key Statistics of Novelstem International Corp (NSTM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.01$0.01

Today's Open

$0.01

Volume

60.00K

P/E Ratio (TTM)

0.21

52 Week Range

$0.01$0.04

Market Cap

493.32K

Avg. Volume

69.39K

Dividend Yield

Financial Metrics & Statements of Novelstem International Corp (NSTM)

FAQ's for Novelstem International Corp (NSTM)

According to Musaffa’s Shariah screening methodology, Novelstem International Corp (NSTM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.